A pharmaceutical company is preparing a first-in-human

clinical trial for a new small-molecule drug. Before selecting a safe starting

dose for healthy volunteers, the compound is administered to animals in a

single-dose, acute pre-clinical toxicity study to assess immediate adverse effects.

Which piece of information from this study would be most

relevant for guiding the choice of the initial human dose?